Target Name: ZNF319
NCBI ID: G57567
Review Report on ZNF319 Target / Biomarker Content of Review Report on ZNF319 Target / Biomarker
ZNF319
Other Name(s): KIAA1388 | Zinc finger protein 319, transcript variant 1 | ZFP319 | Zinc finger protein 319 | ZN319_HUMAN | zinc finger protein 319 | ZNF319 variant 1

ZNF319 (KIAA1388): A Potent Drug Target and Potential Biomarker for treatable Brain Disorders

Abstract:

ZNF319 (KIAA1388) is a non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker for treatable brain disorders. It is a key regulator of neuron development and function, and its abnormal expression has been implicated in a variety of neurological and psychiatric disorders. This review summarizes the current understanding of ZNF319 and its potential as a drug target, as well as its potential as a biomarker for the diagnosis and prognosis of brain disorders.

Introduction:

The zinc finger gene (ZNF) is a family of non-coding RNAs (ncRNAs) that play a crucial role in the regulation of gene expression and development. ZNF319 (KIAA1388) is a member of the ZNF gene family and is expressed in various tissues , including brain. It has been shown to play a role in the development and maintenance of neuronal identity, as well as in modulating the activity of other genes. ZNF319 has also been implicated in the pathophysiology of various psychiatric and neurological disorders, making it an attractive target for drug development.

Drug Target Potential:

ZNF319 has been identified as a potential drug target due to its unique structure and its involvement in multiple cellular processes. It is a small non-coding RNA molecule that contains a zinc finger domain and a conserved domain that is similar to other ZNF proteins. ZNF319 has been shown to play a role in the regulation of neuronal differentiation and in the development of neuronal circuits. It has also been shown to play a role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

In addition to its role in neuronal development and function, ZNF319 has also been shown to play a role in the regulation of inflammation and immune responses. It has been shown to be involved in the regulation of T cell development and in the modulation of inflammation. These functions make ZNF319 an attractive target for the development of new treatments for autoimmune and inflammatory-related disorders.

Biomarker Potential:

ZNF319 has also been shown to be a potential biomarker for the diagnosis and prognosis of various psychiatric and neurological disorders. For example, ZNF319 has been shown to be involved in the regulation of the expression of genes involved in depression, anxiety, and schizophrenia. It has also been shown to be involved in the regulation of the expression of genes involved in Alzheimer's disease, which is the most common form of dementia.

In addition to its potential as a biomarker, ZNF319 has also been shown to be involved in the regulation of gene expression in neurodegenerative disorders. For example, it has been shown to be involved in the regulation of the expression of genes involved in the development of Parkinson's disease and in the regulation of the expression of genes involved in the development of Huntington's disease.

Conclusion:

In conclusion, ZNF319 (KIAA1388) is a non-coding RNA that has been identified as a potential drug target and biomarker for treatable brain disorders. Its unique structure and its involvement in multiple cellular processes make it an attractive target for the development of new treatments . Further research is needed to fully understand the role of ZNF319 in the regulation of neuronal development and function, as well as its potential as a biomarker for the diagnosis and prognosis of various psychiatric and neurological disorders.

Keywords: ZNF319, KIAA1388, Non-coding RNA, RNA target, Drug target, Biomarker, Psychiatric disorder, Neurological disorder, Zinc finger gene,

Protein Name: Zinc Finger Protein 319

Functions: May be involved in transcriptional regulation

The "ZNF319 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF319 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461